Evolve Private Wealth’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
Evolve Private Wealth's CAI Position: Q3 2026 in Review
Evolve Private Wealth opened a new position in Caris Life Sciences (CAI) in Q3 2026: 8,483 shares worth $260K. The stake represents 0.01% of the portfolio and ranks #751 among its holdings.
326 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- Evolve Private Wealth held 8,483 shares of Caris Life Sciences worth $260K as of Q3 2026.
- Caris Life Sciences was a new Evolve Private Wealth position in Q3 2026.
- Caris Life Sciences made up 0.01% of Evolve Private Wealth's portfolio in Q3 2026, its #751 holding.
- 326 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on Evolve Private Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.